Skip to main content
. 2022 Jul 28;131(5):424–441. doi: 10.1161/CIRCRESAHA.122.321187

Figure 3.

Figure 3.

Regulation of UCP2 (uncoupling protein 2) by inflammation and vasoprotective agents. A–C, Real-time quantitative polymerase chain reaction (qPCR) data showing UCP2 mRNA expression is inhibited by proinflammatory mediators IL (interleukin)-1β (10 ng/mL), lysophosphatidylcholine (LPC; 100 μmol/L), and phorbol 12-myristate 13-acetate (PMA; 1 μmol/L), nonparametric Mann-Whitney test. D, Human umbilical vein ECs (HUVECs) treated with simvastatin (SMV, 1 μmol/L), rosuvastatin (RSV, 10 μmol/L), and resveratrol (RES, 50 μmol/L) for 24 h showed upregulated expression of UCP2 mRNA, nonparametric Mann-Whitney test. E, Opposite regulation of UCP2 promoter activity in HUVECs transfected with UCP2 promoter plasmid (581 bp in length) by IL-1β and vasoprotective agents RSV and RES. Two-way ANOVA, Tukey post hoc. F, KLF2 (Krüppel-like factor 2) knockdown in HUVECs by KLF2-shRNA abolished induction of UCP2 mRNA by treatment with SMV, RSV, and RES for 24 h. Two-way ANOVA, Tukey post hoc. G, SMV treatment antagonized the inhibitory effect of IL-1β on UCP2 mRNA expression. Two-way ANOVA, Tukey post hoc. PBS indicates phosphate-buffered saline.